[ad_1]
Alembic Prescribed drugs Restricted on Wednesday introduced that it has acquired last approval from the US well being regulatory, USFDA, for its abbreviated new drug utility of Prazosin Hydrochloride Capsules, which is used for remedy of hypertension. “The accredited ANDA (abbreviated new drug utility) is therapeutically equal to the reference listed drug product (RLD), Minipress Capsules, 1 mg, 2 mg, and 5 mg, of Pfizer Inc,” the corporate mentioned in a launch posted on inventory exchanges.
Prazosin Hydrochloride Capsule, it mentioned, is indicated for the remedy of hypertension, to decrease blood stress.
Prazosin Hydrochloride Capsules USP, 1 mg, 2 mg, and 5 mg have an estimated market measurement of USD 50 million for 12 months ended December 2022, in accordance with IQVIA.
Alembic has a cumulative whole of 183 ANDA approvals (160 last approvals and 23 tentative approvals) from the US Meals & Drug Administration (USFDA).
Headquartered in India, Alembic is a publicly listed firm that manufactures and markets generic pharmaceutical merchandise all around the world. It is likely one of the leaders in branded generics in India.
[ad_2]
Source link
